Interestingly, since IL-6 has been found to be elevated in cancer patients with distal metastases, as compared with non-metastatic patients, an increased IL-6 concentration has been proposed as a prognostic marker in some types of metastatic cancer [37, 38]. The gene discussed is IL6; the disease is cancer.